Viewing nowPlavix 75 mg (Clopidogrel Sulfate)
Clopidogrel Bisulfate 97.875mg
Tablet · Prescription medication
Handok Co., Ltd.

MFDS item code 200700907 · Approved 2007.01.22 · Insurance code 652101570
Improvement of atherosclerosis symptoms, improvement of acute coronary syndrome, and prevention of thromboembolism in atrial fibrillation
This medication is used to improve atherosclerotic symptoms in adult patients with ischemic stroke, myocardial infarction, or peripheral arterial disease. It also reduces the risk of death from cardiovascular events, myocardial infarction, stroke, or refractory ischemia in patients with acute coronary syndrome, such as unstable angina or non-ST elevation myocardial infarction, who have undergone medical treatment, coronary intervention, or coronary artery bypass surgery. In patients with atrial fibrillation who have vascular risk factors and are unsuitable for vitamin K antagonist use with a low risk of bleeding, it helps to reduce the risk of stroke and thromboembolism. It is effective in improving symptoms and reducing risks for various cardiovascular diseases.
1. In patients with ischemic stroke, myocardial infarction, or peripheral arterial disease, administer clopidogrel 75 mg orally once daily. 2. In patients with acute coronary syndrome (unstable angina or non-Q-wave myocardial infarction), administer a loading dose of 300 mg of this medicine once on the day treatment is initiated, followed by a maintenance dose of 75 mg orally once daily. Aspirin 75 ~ 325 mg should be administered once daily in combination with this medicine. 3. In patients with atrial fibrillation, administer 75 mg of this medicine orally once daily. Aspirin 75 ~ 100 mg should be administered once daily in combination with this medicine. This medicine may be administered with or without food.
This medication is a drug that inhibits platelet aggregation in the blood to prevent thrombus formation. In patients with a genetic deficiency of the CYP2C19 enzyme, the effectiveness of this drug may be reduced, in which case alternative treatment options should be considered. Taking this drug with medications that activate the CYP2C19 enzyme may increase the concentration of the active ingredient of this drug and raise the risk of bleeding, so co-administration should be avoided. Patients with allergies to this medication or those with bleeding, severe liver impairment, nursing women, and those with genetic lactose intolerance should not take this medication. Patients at high risk of bleeding or with bleeding disorders, severe liver or kidney dysfunction, acute stroke patients, hypertensive patients, elderly, and underweight patients should take this medication with caution, and it should be discontinued 5-7 days before any scheduled surgery. This medication can cause bleeding; therefore, if any bleeding symptoms occur, consult a physician immediately, especially when combined with other drugs that increase the risk of bleeding. During treatment with this drug, it is important to regularly monitor for bleeding and hematological abnormalities through blood tests and other examinations. This medication may cause various side effects such as gastrointestinal disturbances, diarrhea, rash, headache, and dizziness, and in serious cases, hematologic disorders such as thrombocytopenia or acquired hemophilia can occur. Women who are pregnant or breastfeeding should consult a physician before taking this drug, as the risk of bleeding may increase during pregnancy, warranting caution. This medication may interact with other medications, particularly those associated with bleeding risk, anticoagulants, non-steroidal anti-inflammatory drugs, selective serotonin reuptake inhibitors (SSRIs), and should be discussed with a doctor when used in combination. Overdose may increase the risk of bleeding, and there are no specific antidotes, so if bleeding symptoms occur, you should visit a medical facility immediately. This medication should be kept out of the reach of children, and care must be taken not to store it in different containers, as this could jeopardize its quality.
Hemorrhage, gastrointestinal bleeding, purpura, contusion, hematoma, epistaxis, hematuria, intraocular hemorrhage, intracranial hemorrhage, neutropenia, agranulocytosis, aplastic anemia, thrombocytopenia, abdominal pain, dyspepsia, diarrhea, rash, pruritus, chest pain, accidental injury, influenza-like illness, pain, fatigue, edema, hypertension, headache, dizziness, nausea, depression, upper respiratory tract infection, dyspnea, rhinitis, bronchitis, cough, urinary tract infection, syncope, palpitations, asthenia, fever, hernia, heart failure, atrial fibrillation, leg cramps, sensory impairment, neuralgia, sensory disturbance, vertigo, constipation, vomiting, increased liver enzymes, gout, hyperuricemia, arthralgia, arthritis, anxiety, insomnia, anemia, pneumonia, sinusitis, eczema, skin ulcer, cystitis, cataract, conjunctivitis, gynecomastia, fever, abnormal liver function tests, increased blood creatinine, allergic symptoms, ischemic necrosis, hemorrhagic arthropathy, hematuria, hemoptysis, retroperitoneal hemorrhage, surgical wound bleeding, pulmonary hemorrhage, thrombocytopenia, hypochromic anemia, leukemia, leukopenia, eosinophilia, menorrhagia, hemothorax, herpes zoster, erythematous rash, papular rash, urticaria, renal dysfunction, acute renal failure, cholecystitis, hematemesis, spinal hematoma, vasculitis, hypotension, bronchospasm, interstitial pneumonia, eosinophilic pneumonia, colitis, pancreatitis, gastritis, stomatitis, hepatitis, acute liver failure, papular rash, urticaria, pruritus, angioedema, vesicular dermatitis, drug-induced hypersensitivity syndrome, drug eruption with eosinophilia and systemic symptoms, lichen planus, myalgia, glomerular disease, gynecomastia, fever, decreased motor function, tremor, speech disorder, abnormal gait, hyperkinesia, ataxia, sensory abnormality, insomnia, depression, amnesia, paresthesia, abnormal thinking, abnormal behavior, rigidity, facial edema, purpura, bloody stool, gingival bleeding, visual disturbances, field defects, dry eyes, transient blindness, congestion, tinnitus, taste disturbance, urinary disorders, polyuria, non-protein nitrogen increase, uremia, increased blood urea nitrogen, hypoglycemia, hyperuricemia, increased liver enzymes, elevated ALT, abnormal liver function, leg edema, arrhythmia, bradycardia, palpitations, rash, pruritus, contact dermatitis, gynecomastia, elevated prostate-specific antigen, decreased appetite, weight loss, paresthesia, weight gain, facial flushing, thirst, abnormal thinking, polyuria, arrhythmia, hiccups, dysphagia, tongue disorder, abnormal behavior, field defects, dry eyes, transient blindness, congestion, urinary disorders, uremia, hypoglycemia, bradycardia, tinnitus, contact dermatitis
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to air or moisture and should be stored in a tightly sealed container. It is recommended to maintain storage temperatures between 1 and 30 degrees Celsius to preserve the effectiveness of the drug.
Pink round film-coated tablet
30 tablets (10 tablets/blister x 3), 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowClopidogrel Bisulfate 97.875mg
Tablet · Prescription medication
Handok Co., Ltd.

Clopidogrel Bisulfate 97.875mg
Tablet · Prescription medication
Geonil Pharmaceutical Co., Ltd.
Clopidogrel Bisulfate 97.875mg
Tablet · Prescription medication
Sama Pharmaceutical Co., Ltd.

Clopidogrel Bisulfate 97.875mg
Tablet · Prescription medication
Il Yang Pharmaceutical Co., Ltd.

Clopidogrel Bisulfate 97.875mg
Tablet · Prescription medication
Korea Union Pharmaceutical Co., Ltd.

Clopidogrel Bisulfate 97.875mg
Tablet · Prescription medication
(Co., Ltd.) Korea Pharma

Clopidogrel Bisulfate 97.875mg
Tablet · Prescription medication
Samjin Pharmaceutical Co., Ltd.

Clopidogrel Bisulfate 97.875mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.